A comprehensive dataset revealed that frequent hypermethylation of Klotho promoter results in poor expression of Klotho in colon cancer cells and suggests that DNA methylation alterations could serve as biomarkers for colon cancer. This evidence concerns the gene KL and malignant colon neoplasm.